CN Stock MarketDetailed Quotes

Yabao Pharmaceutical Group (600351)

Watchlist
  • 6.59
  • +0.13+2.01%
Market Closed May 19 15:00 CST
4.56BMarket Cap14.26P/E (TTM)

Yabao Pharmaceutical Group (600351) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical production-Pediatrics635.59M28.37%
Pharmaceutical production-cardiovascular system455.42M20.33%
Medicine wholesale389.76M17.40%
Pharmaceutical production-spiritual nerves185.41M8.28%
Pharmaceutical production-others115.83M5.17%
Other107.88M4.82%
医药生产-消化系统类102.7M4.58%
Pharmaceutical production-Raw Materials94.73M4.23%
Pharmaceutical production-pain relief86.87M3.88%
医药生产-内分泌系统类65.87M2.94%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical production1.8B80.19%
Medicine wholesale389.76M17.40%
Other business30.03M1.34%
Other trade23.87M1.07%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
North China738M32.95%
East China region415.99M18.57%
Central China305.24M13.63%
Southwest area260.09M11.61%
Northwest region191.09M8.53%
South China155.6M6.95%
Northeast area136.95M6.11%
Other business30.03M1.34%
Export business7.08M0.32%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 18 Eastern Time, Trump temporarily halted the planned 'major' military strike on Iran, citing that Gulf allies requested room for neg Show More